000518 四環生物
按盤價 
2.290 +0.040 (+1.778%)
2.290 +0.040 (+1.778%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.618 | -14.490 | -8.389 | -5.580 | 4.350 |
| 總資產報酬率 ROA (%) | -0.451 | -10.760 | -6.347 | -4.287 | 3.138 |
| 投入資產回報率 ROIC (%) | -0.546 | -12.951 | -7.593 | -5.180 | 4.483 | 邊際利潤分析 |
| 銷售毛利率 (%) | 71.545 | 69.761 | 71.035 | 69.418 | 57.868 |
| 營業利潤率 (%) | -7.178 | -32.517 | -20.047 | -10.103 | 7.884 |
| 息稅前利潤/營業總收入 (%) | -6.232 | -32.725 | -19.249 | -9.536 | 7.400 |
| 淨利潤/營業總收入 (%) | -5.727 | -34.158 | -19.723 | -10.905 | 5.472 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 14.301 | 65.806 | 76.611 | 79.812 | 83.518 |
| 價值變動淨收益/利潤總額(%) | -1.416 | -2.175 | 0.487 | 1.507 | -0.069 |
| 營業外收支淨額/利潤總額(%) | 0.226 | 3.618 | -1.028 | 1.602 | -9.356 | 償債能力分析 |
| 流動比率 (X) | 4.398 | 4.311 | 4.860 | 5.131 | 4.859 |
| 速動比率 (X) | 0.831 | 0.854 | 1.343 | 1.569 | 1.597 |
| 資產負債率 (%) | 22.026 | 22.421 | 19.589 | 19.083 | 16.834 |
| 帶息債務/全部投入資本 (%) | 6.417 | 6.037 | 5.202 | 4.463 | -- |
| 股東權益/帶息債務 (%) | 1,375.300 | 1,464.978 | 1,734.084 | 2,034.423 | 1,883.013 |
| 股東權益/負債合計 (%) | 332.594 | 325.050 | 385.412 | 397.306 | 462.156 |
| 利息保障倍數 (X) | -6.474 | -32.322 | -32.414 | -13.019 | 38.810 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 108.154 | 129.931 | 146.201 | 130.011 | 0.000 |
| 存貨周轉天數 (天) | 2,296.508 | 2,066.560 | 1,930.987 | 1,475.480 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/04/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
